Cholesterol Testing Products And Services Market To Reach $31.98 Billion By 2030

Cholesterol Testing Products And Services Market Growth & Trends

The global cholesterol testing products and services market size is expected to reach USD 31.98 billion by 2030, registering a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Insufficient physical activity leads to high cholesterol levels and other conditions, such as obesity, diabetes, and cardiovascular diseases. This factor is anticipated to drive the demand for cholesterol testing products and services in near future.

There is an increased need to control high blood cholesterol levels, in addition to other risk factors such as smoking, high blood pressure, and obesity. This has led to high adoption of diagnostic tools and services. According to the Journal of the American Medical Association (JAMA), while the cholesterol levels in the U.S. youth have improved from 1999 to 2016, only 50% of adolescents and children have the ideal cholesterol range and 25% of them are in the clinically high range.

According to the Journal of the American College of Cardiology, in 2018, 31 million of the U.S. adults had high total cholesterol and around one-third of them had high levels of Low-Density Lipoprotein (LDL). Growing number of people being overweight in U.S. is another factor driving the demand for cholesterol testing products and services. Increasing geriatric population is one of the significant factors driving the market growth. This group of population is prone to various cardiovascular diseases such as stroke and heart attack. Thus, increasing cholesterol level is a substantial risk factor for the aging population, which is expected to drive the product demand.

 Request a free sample copy or view report summary: Cholesterol Testing Products And Services Market Report

Cholesterol Testing Products And Services Market Report Highlights

• Testing kits led the market and accounted for a share of 45.8% in 2024. Testing kits provide convenience and user-friendliness, enabling individuals to perform tests at home without laboratory visits.

• Total cholesterol tests dominated the market with a revenue share of 38.6% in 2024. Total cholesterol tests offer a thorough evaluation of an individual’s cholesterol levels, including high density lipoprotein (HDL), LDL, and triglycerides.

• The geriatric segment held the largest revenue share of 46.9% in 2024, aided by the rising prevalence of high cholesterol and cardiovascular diseases (CVDs) among older adults.

• Cardiovascular diseases led the market with a revenue share of 35.5% in 2024, supported by the rising incidence of CVDs, a leading cause of global mortality.

• Hospitals and clinics dominated the market, accounting for a share of 39.1% in 2024. These facilities utilize advanced diagnostic technologies and are staffed by trained professionals to ensure accurate and efficient cholesterol testing.

Cholesterol Testing Products And Services Market Segmentation

Grand View Research has segmented global cholesterol testing products and services market report based on product, test, age group, application, service provider, and region:

Cholesterol Testing Products And Services Product Outlook (Revenue, USD Million, 2018 - 2030)

• Testing Kits

• Testing Strips

• Others

Cholesterol Testing Products And Services Test Outlook (Revenue, USD Million, 2018 - 2030)

• Total Cholesterol Tests

• High Density Lipoprotein (HDL) Cholesterol Tests

• Low Density Lipoprotein (LDL) Cholesterol Tests

• Triglyceride Tests

• Others

Cholesterol Testing Products And Services Age Group Outlook (Revenue, USD Million, 2018 - 2030)

• Geriatric

• Adult

• Pediatric

Cholesterol Testing Products And Services Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiovascular Diseases

• Diabetes

• Obesity

• Hyperlipidemia

• Others

Cholesterol Testing Products And Services Service Provider Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals and Clinics

• Diagnostic Laboratories

• Ambulatory Care Centers

• Others

Cholesterol Testing Products And Services Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Cholesterol Testing Products And Services Market

• Quest Diagnostics Incorporated

• Eurofins Scientific

• Spectra Laboratories, Inc. (Fresenius Medical Care)

• Novartis AG

• Cell Biolabs, Inc.

• Randox Laboratories Ltd.

• SYNLAB AG

• BioReference Health, LLC

• Laboratory Corporation of America Holdings

• Thermo Fisher Scientific Inc.

• Clinical Reference Laboratory, Inc.

• Elabscience Bionovation Inc.